Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01521923
Brief Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

First Submitted : January 19, 2012
First Submitted that Met QC Criteria : January 26, 2012
First Posted : January 31, 2012 (Estimate)

Results First Submitted : July 6, 2016
Results First Submitted that Met QC Criteria : November 10, 2016
Results First Posted : January 10, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : July 4, 2018
Last Update Posted : July 31, 2018